Local tumor treatments for metastatic cancer
Part of Cancer clinical trials.
This trial tests a combination of two local treatments for people with many or large tumors that have spread. The goal is to control the tumors and possibly improve outcomes without surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 years or older
- Confirmed cancer that has spread to other parts of the body
- Have at least 3 metastatic lesions or at least one large tumor (≥7 cm or ≥100 mL in volume)
- Have 2 to 5 tumors that are suitable for needle-based local treatments
- Be in reasonably good physical condition (ECOG 0-2)
- No strong contraindications such as recent heart attack, severe COPD, or uncontrolled infection
- Treated and stable brain metastases are allowed; untreated or unstable brain metastases are not eligible
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination approach for people with cancer that has spread to multiple spots outside the brain. It uses a procedure that places tiny radioactive seeds directly into the tumor, along with standard systemic therapy (like chemo or immunotherapy), to see if this helps control the cancer better.
This study compares giving two local treatments together (radioactive seed implantation followed by freezing) versus just one of those treatments for solid tumors that cannot be removed with surgery. The hope is that combining them works better at controlling the tumor. You would be randomly assigned to either the combination or to a single treatment.
This study combines tiny radioactive seeds placed directly into tumors with an immunotherapy drug that helps the immune system fight cancer. It is for patients with advanced or returning tumors that have not responded well to other treatments, and aims to see if this combination can shrink tumors and improve outcomes.
This study is testing a treatment that implants tiny radioactive seeds (brachytherapy) directly into a few growing cancer spots, along with your regular systemic therapy, for people with lung or colorectal cancer that has spread. It aims to control those growing spots and potentially improve how long the treatment keeps working.
This study is for people with solid tumors that have spread to a few spots (5 or fewer) in the body. It tests whether using a focused treatment like radiation or ablation on those spots can help control the cancer long-term.
This trial tests whether using local treatments (like targeted radiation or ablation) on a few new spots of cancer can help people whose cancer is otherwise stable on their current treatment. It enrolls people with various solid tumors, such as breast, gynecologic, head & neck, sarcoma, or other types.
Hear when a new High-Burden Metastatic Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.